Orthocell Limited is a regenerative medicine company developing therapies for soft tissue repair and nerve regeneration. Its products target musculoskeletal conditions, aiming to improve patient recovery outcomes.
Ticker code: OCC
Sector: Healthcare | Industry: Biotechnology | Website: https://orthocell.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $275,156,548 | $247,113,515 | 271090199.0 | 76.13 | $209,476,804 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $16,265,412 | $28,619,928 | $576,895 | 0.0 | -67.6 | -172.4 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 14.4 | $345,513 | $809,714 | 0.8 | 2.7 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | 0.0 |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $1.015 | -2.9 | -0.5 | -8.1 | -10.2 | -20.4 | 5.7 |
OCC Price Chart with Volume and 3EMA
OCC Short Positions
Click HERE to understand why the above moving averages have been chosen.